GoodRx Holdings, Inc. (GDRX)

2.24 0.02 (0.9%)

As of 2026-02-18 02:05:04 EST

GoodRx Holdings, Inc. is an American healthcare company that operates a telemedicine platform and free-to-use website and mobile app that track prescription drug prices in the United States and provide drug coupons for discounts on medications. GoodRx compares prescription drug prices at more than 75,000 pharmacies in the United States. The platform allows users to consult a doctor online and obtain a prescription for certain types of medications.

Traded asNasdaq: GDRX
ISINUS38246G1085
CIK0001809519
LEI529900ATKYECI45EHV09
EIN475104396
Sector—
IndustryServices-Computer Processing & Data Preparation
CEOWendy Barnes
Employees738
Fiscal Year End1231
Address2701 OLYMPIC BOULEVARD, SANTA MONICA, CA, 90404
Phone(855) 268-2822
Websitehttp://goodrx.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
GDRXGoodRx Holdings, Inc.2026-02-18 02:05:042.240.020.9
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
GDRX0001809519GoodRx Holdings, Inc.US38246G1085529900ATKYECI45EHV09475104396Nasdaq7374Services-Computer Processing & Data Preparation1231DE2701 OLYMPIC BOULEVARDSANTA MONICACA90404UNITED STATESUS(855) 268-28222701 OLYMPIC BOULEVARD, SANTA MONICA, CA, 904042701 OLYMPIC BOULEVARD, SANTA MONICA, CA, 90404——2011Wendy Barnes738http://goodrx.com646,300,000——GoodRx Holdings, Inc. is an American healthcare company that operates a telemedicine platform and free-to-use website and mobile app that track prescription drug prices in the United States and provide drug coupons for discounts on medications. GoodRx compares prescription drug prices at more than 75,000 pharmacies in the United States. The platform allows users to consult a doctor online and obtain a prescription for certain types of medications.2026-02-12 18:08:55
This is a preview of the latest data. Subscribe to access the full data.
GDRX Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
GDRX Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
2024646,300,000222,400,00052.4652———
2023423,900,000-48,200,000-10.2097———
2022472,100,000-1,827,900,000-79.4739———
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Trevor BezdekChairman Of The Board2024500,0003980302,30051,220853,918
Romin NabieyChief Accounting Officer2024326,627286257,87098,5209,303942,603
Scott WagnerChief Executive Officer2024750,000750,2123,902,298363,9699979,767,472
Karsten VoermannChief Financial Officer2024450,0004432,578,753272,07035,3385,836,601
Raj BeriChief Operating Officer202462,5000001,916,5552,878,472
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
2024738
2023694
2022954
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202420232022
Revenue792,324,000750,265,000766,554,000
Cost Of Revenue48,215,00066,925,00065,079,000
Gross Profit———
Research And Development Expenses123,749,000135,836,000143,137,000
General And Administrative Expenses117,862,000125,515,000144,792,000
Operating Expenses726,478,000777,272,000764,816,000
Operating Income65,846,000-27,007,0001,738,000
Net Income16,390,000-8,868,000-32,828,000
Earnings Per Share Basic0.04-0.02-0.08
Earnings Per Share Diluted0.04-0.02-0.08
Weighted Average Shares Outstanding Basic385,737,000410,315,000412,858,000
Weighted Average Shares Outstanding Diluted392,172,000410,315,000412,858,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202420232022
Cash And Cash Equivalents448,346,000672,296,000757,165,000
Marketable Securities Current———
Accounts Receivable145,934,000143,608,000117,141,000
Inventories———
Non Trade Receivables03,537,0004,524,000
Other Assets Current——35,105,000
Total Assets Current659,255,000872,790,000919,686,000
Marketable Securities Non Current———
Property Plant And Equipment12,664,00015,932,00019,820,000
Other Assets Non Current23,520,00037,775,00027,165,000
Total Assets Non Current728,812,000716,010,000684,945,000
Total Assets1,388,067,0001,588,800,0001,604,631,000
Accounts Payable14,137,00036,266,00017,700,000
Deferred Revenue6,036,0007,105,0007,879,000
Short Term Debt5,000,0008,787,0007,029,000
Other Liabilities Current1,457,000——
Total Liabilities Current123,903,000122,559,00076,320,000
Long Term Debt500,000,000647,703,000667,068,000
Other Liabilities Non Current6,755,0008,177,0007,557,000
Total Liabilities Non Current539,506,000704,283,000713,484,000
Total Liabilities663,409,000826,842,000789,804,000
Common Stock38,00040,00040,000
Retained Earnings-1,441,013,000-1,457,403,000-1,448,535,000
Accumulated Other Comprehensive Income———
Total Shareholders Equity724,658,000761,958,000814,827,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202420232022
Depreciation And Amortization69,538,000107,668,00054,177,000
Share Based Compensation Expense99,026,000104,820,000120,234,000
Other Non Cash Income Expense0-1,348,000—
Change In Accounts Receivable2,326,00026,467,000-1,375,000
Change In Inventories———
Change In Non Trade Receivables———
Change In Other Assets-164,000164,000-80,000
Change In Accounts Payable-21,241,00017,456,000-874,000
Change In Other Liabilities-1,422,000914,0002,125,000
Cash From Operating Activities183,892,000138,292,000146,780,000
Purchases Of Marketable Securities———
Sales Of Marketable Securities———
Acquisition Of Property Plant And Equipment1,240,0001,043,0003,967,000
Acquisition Of Business00156,853,000
Other Investing Activities———
Cash From Investing Activities-70,347,000-55,766,000-210,498,000
Tax Withholding For Share Based Compensation———
Payments Of Dividends———
Issuance Of Common Stock1,766,0001,390,000—
Repurchase Of Common Stock159,704,000103,974,000101,721,000
Issuance Of Long Term Debt472,033,000—0
Repayment Of Long Term Debt639,038,0005,271,0007,029,000
Other Financing Activities———
Cash From Financing Activities-337,495,000-167,395,000-120,226,000
Change In Cash-223,950,000-84,869,000-183,944,000
Cash At End Of Period448,346,000672,296,000757,165,000
Income Taxes Paid23,623,00017,243,0004,356,000
Interest Paid55,099,00048,799,00030,702,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202420232022
Earnings Per Share0.04-0.02-0.08
Price To Earnings Ratio116.25-335-58.25
Earnings Growth Rate-300-7533.3333
Price Earnings To Growth Ratio-0.38754.4667-1.7475
Book Value Per Share1.87861.8571.9736
Price To Book Ratio2.47523.6082.3611
Ebitda162,473,000172,771,00059,948,000
Enterprise Value1,850,331,0502,733,304,5001,840,850,280
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio0.69690.86160.8273
Capital Expenditures66,270,000103,780,00052,385,000
Free Cash Flow117,622,00034,512,00094,395,000
Return On Equity0.0226-0.0116-0.0403
One Year Beta0.82141.97852.1936
Three Year Beta1.93162.01211.9432
Five Year Beta1.8051.95041.9432
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Nabiey RominChief Accounting Officer2026-02-154,804A177,727
Nabiey RominChief Accounting Officer2026-02-151,979D175,748
Nabiey RominChief Accounting Officer2026-02-154,804D57,650
McGinnis Christopher A—2026-02-15179,120A179,120
McGinnis Christopher A—2026-02-1552,799D126,321
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Anthony E. Gonzalez2021-04-23OH16Purchase2021-03-25—$100,001 - $250,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Cetera Investment Advisers2025-12-3127,69410,2192.71
AQR CAPITAL MANAGEMENT LLC2025-12-313,139,6601,158,5462.71
Jain Global LLC2025-12-31269,43999,4242.71
PharVision Advisers, LLC2025-12-31342,609126,4242.71
TUDOR INVESTMENT CORP ET AL2025-12-31141,73352,3002.71
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
RBB FUND, INC.2025-11-30Motley Fool Next Index ETFTMFX5,48215,404.420.0463
VANGUARD WORLD FUND2025-11-30ETF SharesVHT261,804735,669.240.0036
VANGUARD WORLD FUND2025-11-30Admiral SharesVHCIX261,804735,669.240.0036
AMERICAN CENTURY ETF TRUST2025-11-30Avantis U.S. Small Cap Equity ETFAVSC89,627251,851.870.0124
AMERICAN CENTURY ETF TRUST2025-11-30Institutional ClassAVSCX9372,632.970.0022
This is a preview of the latest data. Subscribe to access the full data.